Matches in SemOpenAlex for { <https://semopenalex.org/work/W2396280219> ?p ?o ?g. }
- W2396280219 endingPage "39995" @default.
- W2396280219 startingPage "39980" @default.
- W2396280219 abstract "// Simone Buraschi 1, * , Shi-Qiong Xu 2, * , Manuela Stefanello 2 , Igor Moskalev 3 , Alaide Morcavallo 2 , Marco Genua 2 , Ryuta Tanimoto 2 , Ruth Birbe 1 , Stephen C. Peiper 1 , Leonard G. Gomella 2 , Antonino Belfiore 4 , Peter C. Black 3 , Renato V. Iozzo 1 , Andrea Morrione 2 1 Department of Pathology, Anatomy and Cell Biology and The Cancer Cell Biology and Signaling Program, Kimmel Cancer Center, Thomas Jefferson University, PA, Philadelphia, USA 2 Department of Urology and Biology and The Prostate Cancer Program, Kimmel Cancer Center, Thomas Jefferson University, PA, Philadelphia, USA 3 Vancouver Prostate Centre, Department of Urologic Sciences, University of British Columbia, Vancouver, Canada 4 Department of Health and Endocrinology, University Magna Graecia of Catanzaro, Catanzaro, Italy * These authors contributed equally to this work Correspondence to: Andrea Morrione, email: Andrea.Morrione@jefferson.edu Renato V. Iozzo, email: renato.iozzo@jefferson.edu Keywords: progranulin, bladder cancer, motility, anchorage-independent growth, tumor formation in vivo Received: January 21, 2016 Accepted: May 08, 2016 Published: May 23, 2016 ABSTRACT We have recently demonstrated a critical role for progranulin in bladder cancer. Progranulin contributes, as an autocrine growth factor, to the transformed phenotype by modulating Akt-and MAPK-driven motility, invasion and anchorage-independent growth. Progranulin also induces F-actin remodeling by interacting with the F-actin binding protein drebrin. In addition, progranulin is overexpressed in invasive bladder cancer compared to normal tissue controls, suggesting that progranulin might play a key role in driving the transition to the invasive phenotype of urothelial cancer. However, it is not established whether targeting progranulin could have therapeutic effects on bladder cancer. In this study, we stably depleted urothelial cancer cells of endogenous progranulin by shRNA approaches and determined that progranulin depletion severely inhibited the ability of tumorigenic urothelial cancer cells to migrate, invade and grow in anchorage-independency. We further demonstrate that progranulin expression is critical for tumor growth in vivo , in both xenograft and orthotopic tumor models. Notably, progranulin levels correlated with response to cisplatin treatment and were upregulated in bladder tumors. Our data indicate that progranulin may constitute a novel target for therapeutic intervention in bladder tumors. In addition, progranulin may serve as a novel biomarker for bladder cancer." @default.
- W2396280219 created "2016-06-24" @default.
- W2396280219 creator A5000431579 @default.
- W2396280219 creator A5014170816 @default.
- W2396280219 creator A5037187770 @default.
- W2396280219 creator A5038861339 @default.
- W2396280219 creator A5044079883 @default.
- W2396280219 creator A5047586304 @default.
- W2396280219 creator A5050196540 @default.
- W2396280219 creator A5051948912 @default.
- W2396280219 creator A5057947764 @default.
- W2396280219 creator A5058553028 @default.
- W2396280219 creator A5071741514 @default.
- W2396280219 creator A5074384753 @default.
- W2396280219 creator A5083134524 @default.
- W2396280219 creator A5084413995 @default.
- W2396280219 date "2016-05-23" @default.
- W2396280219 modified "2023-10-03" @default.
- W2396280219 title "Suppression of progranulin expression inhibits bladder cancer growth and sensitizes cancer cells to cisplatin" @default.
- W2396280219 cites W1554725394 @default.
- W2396280219 cites W1559233041 @default.
- W2396280219 cites W172279490 @default.
- W2396280219 cites W1769779196 @default.
- W2396280219 cites W1917915960 @default.
- W2396280219 cites W1964226422 @default.
- W2396280219 cites W1964251746 @default.
- W2396280219 cites W1964847767 @default.
- W2396280219 cites W1975918912 @default.
- W2396280219 cites W1977339855 @default.
- W2396280219 cites W1986808693 @default.
- W2396280219 cites W1997628453 @default.
- W2396280219 cites W2005731595 @default.
- W2396280219 cites W2007583349 @default.
- W2396280219 cites W2020719670 @default.
- W2396280219 cites W2024515893 @default.
- W2396280219 cites W2027460468 @default.
- W2396280219 cites W2033775272 @default.
- W2396280219 cites W2038099835 @default.
- W2396280219 cites W2041007653 @default.
- W2396280219 cites W2045921574 @default.
- W2396280219 cites W2053493373 @default.
- W2396280219 cites W2058229406 @default.
- W2396280219 cites W2066874573 @default.
- W2396280219 cites W2067964015 @default.
- W2396280219 cites W2068523052 @default.
- W2396280219 cites W2068681851 @default.
- W2396280219 cites W2073164785 @default.
- W2396280219 cites W2074349856 @default.
- W2396280219 cites W2074751736 @default.
- W2396280219 cites W2080232352 @default.
- W2396280219 cites W2083237528 @default.
- W2396280219 cites W2086274716 @default.
- W2396280219 cites W2086898489 @default.
- W2396280219 cites W2095031099 @default.
- W2396280219 cites W2095973840 @default.
- W2396280219 cites W2098208235 @default.
- W2396280219 cites W2103029879 @default.
- W2396280219 cites W2113365168 @default.
- W2396280219 cites W2123638436 @default.
- W2396280219 cites W2124614719 @default.
- W2396280219 cites W2135101100 @default.
- W2396280219 cites W2148500292 @default.
- W2396280219 cites W2148514581 @default.
- W2396280219 cites W2154045814 @default.
- W2396280219 cites W2166816242 @default.
- W2396280219 cites W2170552969 @default.
- W2396280219 cites W2184354205 @default.
- W2396280219 cites W2325479989 @default.
- W2396280219 cites W2046725802 @default.
- W2396280219 doi "https://doi.org/10.18632/oncotarget.9556" @default.
- W2396280219 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5129986" @default.
- W2396280219 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27220888" @default.
- W2396280219 hasPublicationYear "2016" @default.
- W2396280219 type Work @default.
- W2396280219 sameAs 2396280219 @default.
- W2396280219 citedByCount "24" @default.
- W2396280219 countsByYear W23962802192016 @default.
- W2396280219 countsByYear W23962802192017 @default.
- W2396280219 countsByYear W23962802192018 @default.
- W2396280219 countsByYear W23962802192019 @default.
- W2396280219 countsByYear W23962802192020 @default.
- W2396280219 countsByYear W23962802192021 @default.
- W2396280219 countsByYear W23962802192022 @default.
- W2396280219 countsByYear W23962802192023 @default.
- W2396280219 crossrefType "journal-article" @default.
- W2396280219 hasAuthorship W2396280219A5000431579 @default.
- W2396280219 hasAuthorship W2396280219A5014170816 @default.
- W2396280219 hasAuthorship W2396280219A5037187770 @default.
- W2396280219 hasAuthorship W2396280219A5038861339 @default.
- W2396280219 hasAuthorship W2396280219A5044079883 @default.
- W2396280219 hasAuthorship W2396280219A5047586304 @default.
- W2396280219 hasAuthorship W2396280219A5050196540 @default.
- W2396280219 hasAuthorship W2396280219A5051948912 @default.
- W2396280219 hasAuthorship W2396280219A5057947764 @default.
- W2396280219 hasAuthorship W2396280219A5058553028 @default.
- W2396280219 hasAuthorship W2396280219A5071741514 @default.
- W2396280219 hasAuthorship W2396280219A5074384753 @default.
- W2396280219 hasAuthorship W2396280219A5083134524 @default.